In-depth Research Report of Global Transdermal Patch Market (2019 Version)


Report ID : RNR-263683 Category : Pharma Healthcare Published Date : 19-Mar-19
Publisher : Lilan Data & Info Pages : 134 Format : PDF
The Report mainly includes sales, revenue, trade, competition, investment, forecast and marketing of the product and the segments here include companies, types, applications, regions, countries, etc. 

The Global  market of Transdermal Patch is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new LDI (Lilan Data & Info) study.

The regions of Transdermal Patch contain all Global  market, especially in North America, Europe, Asia Pacific, Latin America and MEA. 

Players include Hisamitsu Pharmaceutical, Novartis, Johnson & Johnson, Teikoku Pharma, Mylan, Actavis, Mundipharma, Henan Lingrui Pharmaceutical, Changzhou Siyao, Rfl Pharmaceutical, etc.

Types cover Fentanyl Transdermal Patch, Nicotine Transdermal Patch, Buprenorphine Transdermal Patch, Clonidine Transdermal Patch, Oxybutynin Transdermal Patch, Others, etc. and applications cover The fentanyl transdermal system (patch) is used for the management of persistent, moderate to severe chronic pain in opioid-tolerant patients when a continuous, around-the-clock opioid analgesic is needed for an extended period of time., Nicotine skin patches are used to help people stop smoking cigarettes. They provide a source of nicotine that reduces the withdrawal symptoms experienced when smoking is stopped., Buprenorphine patches are used to relieve severe pain in people who are expected to need pain medication around the clock for a long time and who cannot be treated with other medications. It is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain., Transdermal clonidine is used alone or in combination with other medications to treat high blood pressure. Clonidine is in a class of medications called centrally acting alpha-agonist hypotensive agents. It works by decreasing your heart rate and relaxing the blood vessels so that blood can flow more easily through the body., Oxybutynin transdermal patches are used to treat an overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination). Oxybutynin is in a class of medications called antimuscarinics. It works by relaxing the bladder muscles., Others, etc.

There are 11 Chapters to deeply display the global Transdermal Patch market.
Chapter 1, is  definition and segment of Transdermal Patch;
Chapter 2, is executive summary of Transdermal Patch Market;
Chapter 3, to explain the industry chain of Transdermal Patch;
Chapter 4, to show info and data comparison of  Transdermal Patch Players;
Chapter 5, to show comparison of types;
Chapter 6, to show comparison of applications;
Chapter 7, to show comparison of regions and coutries(or sub-regions);
Chapter 8, to show competition and trade situation of Transdermal Patch Market;
Chapter 9, to forecast Transdermal Patch market in the next years;
Chapter 10, to show investment of Transdermal Patch Market;
Table of Contents

Chap. 1, Definition and Segment
    1.1, Definition
    1.2, Segments
        A, Type Segment
        B, Application Segment
        C, Regional Segment

Chap. 2, Executive Summary of Transdermal Patch Market

Chap. 3, Industrial Chain Analysis of Transdermal Patch Market
    3.1, Industrial Chain of Transdermal Patch
    3.2, Production Process of Transdermal Patch
    3.3, Upstream and Cost of Transdermal Patch
        A, Raw Materials Cost
        B, Equipment Market
        C, Labor Cost Analysis
        D, Cost Structure Analysis
    3.4, Distribution
        A, Marketing Channel
        B, Distributors/Agents
    3.5, Downstream

Chap. 4, Comparison of Companies
    4.1, Comprehensive Analysis of Transdermal Patch Companies
        4.1.1, Business Comparison of Companies
        4.1.2, Transdermal Patch Business Distribution by Companies
        4.1.3, Transdermal Patch Product Comparison by Companies
    4.2, Transdermal Patch Sales and Revenue by Companies
    4.3, Data Details (Sales, Revenue, Price, Share, Growth Rate, Gross Margin) Analysis of Transdermal Patch by Companies
        Comp. 1: Data Details (Sales, Revenue, Price, Share, Growth Rate, Gross Margin) of Hisamitsu Pharmaceutical
        Comp. 2: Data Details of Novartis
        Comp. 3: Data Details of Johnson & Johnson
        Comp. 4: Data Details of Teikoku Pharma
        Comp. 5: Data Details of Mylan
        Comp. 6: Data Details of Actavis
        Comp. 7: Data Details of Mundipharma
        Comp. 8: Data Details of Henan Lingrui Pharmaceutical
        Comp. 9: Data Details of Changzhou Siyao
        Comp. 10: Data Details of Rfl Pharmaceutical

Chap. 5, Comparison of Types (Sales, Revenue, Share, Price, Growth)
    5.1, Fentanyl Transdermal Patch
    5.2, Nicotine Transdermal Patch
    5.3, Buprenorphine Transdermal Patch
    5.4, Clonidine Transdermal Patch
    5.5, Oxybutynin Transdermal Patch
    5.6, Others

Chap. 6, Comparison of Applications (Sales, Share, Growth)
    6.1, The fentanyl transdermal system (patch) is used for the management of persistent, moderate to severe chronic pain in opioid-tolerant patients when a continuous, around-the-clock opioid analgesic is needed for an extended period of time.
    6.2, Nicotine skin patches are used to help people stop smoking cigarettes. They provide a source of nicotine that reduces the withdrawal symptoms experienced when smoking is stopped.
    6.3, Buprenorphine patches are used to relieve severe pain in people who are expected to need pain medication around the clock for a long time and who cannot be treated with other medications. It is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain.
    6.4, Transdermal clonidine is used alone or in combination with other medications to treat high blood pressure. Clonidine is in a class of medications called centrally acting alpha-agonist hypotensive agents. It works by decreasing your heart rate and relaxing the blood vessels so that blood can flow more easily through the body.
    6.5, Oxybutynin transdermal patches are used to treat an overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination). Oxybutynin is in a class of medications called antimuscarinics. It works by relaxing the bladder muscles.
    6.6, Others

Chap. 7, Comparison of Regions (Sales, Price, Revenue, Share, Growth)
    7.1, North America
        7.1.1, Sub-regions of North America
        7.1.2, U.S.A.
        7.1.3, Canada
    7.2, Europe
        7.2.1 Sub-regions of Europe
        7.2.2, Germany
        7.2.3, U.K.
        7.2.4, France
        7.2.5, Italy
        7.2.6, Spain
    7.3, Asia Pacific
        7.3.1, Sub-regions of Asia Pacific
        7.3.2, China
        7.3.3, India
        7.3.4, Japan
        7.3.5, Oceania
        7.3.6, SEA
    7.4, Latin America
        7.4.1, Sub-regions of Latin America
        7.4.2, Brazil
        7.4.3, Mexico
    7.5, MEA
        7.5.1, Sub-regions of MEA
        7.5.2, Mid-east
        7.5.3, South Africa

Chap. 8, Competition and Trade Situation Analysis of Transdermal Patch Market
    8.1, Competition Situation by Players
        8.1.1, Market Concentration by Players
        8.1.2, Mergers & Acquisitions, Expansions
        8.1.3, New Entrants
    8.2, Competition Situation by Regions
    8.3, Trade Situation by Regions
        8.3.1, Trade Data (Import and Export) of North America
        8.3.2, Trade Data of Europe
        8.3.3, Trade Data of Asia Pacific
        8.3.4, Trade Data of Latin America
        8.3.5, Trade Data of MEA

Chap. 9, Forecast of Transdermal Patch Market
    9.1, Market Size Forecast
        9.1.1, Opportunity
        9.1.2, Restraints
        9.1.3, Market Trend (Sales, Revenue)
    9.2, Types Forecast (Sales, Revenue)
    9.3, Application Forecast (Sales)
    9.4, Regional Forecast (Sales, Revenue)

Chap. 10, Investment Analysis of Transdermal Patch Market
    10.1, Investment Opportunity
    10.2, Investment Calculation
        10.2.1, Cost Calculation
        10.2.2, Revenue Calculation
        10.2.3, Economic Performance Evaluation

Chap. 11, Appendix (Free Info)
    11.1, Profiles and Transdermal Patch Product Information of Key Companies
        Comp. 1: (Profiles and Transdermal Patch Product Information of) Hisamitsu Pharmaceutical
        Comp. 2: Novartis
        Comp. 3: Johnson & Johnson
        Comp. 4: Teikoku Pharma
        Comp. 5: Mylan
        Comp. 6: Actavis
        Comp. 7: Mundipharma
        Comp. 8: Henan Lingrui Pharmaceutical
        Comp. 9: Changzhou Siyao
        Comp. 10: Rfl Pharmaceutical
    11.2, Contact Info of Related Companies
    11.3, Assumptions and Research Methodology
    11.4, Average Annual Exchange Rate
    11.5, Global and Regional Economic Change
    11.6, Global and Regional Labor Cost Index
    11.7, Relevant Policy (Examples)
    11.8, Relevant Patent and Technological Innovation (Examples)
    11.9, Info & Data Source
    11.10, Details of Abbreviated Words
    11.11, Disclaimer
    11.12, Author List